Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles

J Virol. 1995 Mar;69(3):1444-51. doi: 10.1128/JVI.69.3.1444-1451.1995.

Abstract

A reverse genetics approach which allows the generation of infectious defective rabies virus (RV) particles entirely from plasmid-encoded genomes and proteins (K.-K. Conzelmann and M. Schnell, J. Virol. 68:713-719, 1994) was used to investigate the ability of a heterologous lyssavirus glycoprotein (G) and chimeric G constructs to function in the formation of infectious RV-like particles. Virions containing a chloramphenicol acetyltransferase (CAT) reporter gene (SDI-CAT) were generated in cells simultaneously expressing the genomic RNA analog, the RV N, P, M, and L proteins, and engineered G constructs from transfected plasmids. The infectivity of particles was determined by a CAT assay after passage to helper virus-infected cells. The heterologous G protein from Eth-16 virus (Mokola virus, lyssavirus serotype 3) as well as a construct in which the ectodomain of RV G was fused to the cytoplasmic and transmembrane domains of the Eth-16 virus G rescued infectious SDI-CAT particles. In contrast, a chimeric protein composed of the amino-terminal half of the Eth-16 virus G and the carboxy-terminal half of RV G failed to produce infectious particles. Site-directed mutagenesis was used to convert the antigenic site III of RV G to the corresponding sequence of Eth-16 G. This chimeric protein rescued infectious SDI-CAT particles as efficiently as RV G. Virions containing the chimeric protein were specifically neutralized by an anti-Eth-16 virus serum and escaped neutralization by a monoclonal antibody directed against RV antigenic site III. The results show that entire structural domains as well as short surface epitopes of lyssavirus G proteins may be exchanged without affecting the structure required to mediate infection of cells.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Viral / chemistry
  • Base Sequence
  • Cloning, Molecular
  • Defective Viruses / chemistry
  • Genes
  • Lyssavirus / chemistry*
  • Lyssavirus / genetics
  • Lyssavirus / growth & development
  • Membrane Glycoproteins / genetics
  • Molecular Sequence Data
  • Rabies virus / chemistry*
  • Rabies virus / growth & development
  • Recombinant Fusion Proteins / chemistry
  • Sequence Alignment
  • Sequence Homology, Amino Acid
  • Viral Fusion Proteins / genetics
  • Viral Fusion Proteins / physiology*
  • Viral Vaccines / chemistry*
  • Virus Replication

Substances

  • Antigens, Viral
  • Membrane Glycoproteins
  • Mokola virus glycoprotein vaccine
  • Recombinant Fusion Proteins
  • Viral Fusion Proteins
  • Viral Vaccines

Associated data

  • GENBANK/U17064